Patient Engagement. It means different things to different people. Until recently, the term was mostly used by corporations as a euphemism for brand loyalty to their medical products, or by healthcare providers as the antidote to “noncompliance.” We at the ‘Mine think of engagement not so much as what others convince us to do, but as a chance for patients to take the reigns, acting as catalysts for change themselves. That’s what the DiabetesMine Innovation…Read more »
If you’ve ever seen a dietician, the appointment probably took place in a medical office setting of some sort. There may have been some plastic food replicas involved, but most likely the health care professional didn’t follow you around as you purchased real groceries, keeping watch over your choices.
But that kind of real-life assistance could soon be a reality, if a Pittsburgh company’s dreams come true.
The company, called Connect & Coach is attempting…
Last week marked the big European Association for the Study of Diabetes (EASD) taking place this year in Barcelona, Spain. Like the annual American Diabetes Association’s Scientific Sessions, this gathering draws thousands from the scientific, medical and research spheres to talk about diabetes advances.
We unfortunately weren’t able to make it to Barcelona ourselves (boo!), but have been watching the news announcements closely. Plus, one of our 2013 Patient Voices Contest winners who happens to…
Getting to know the people behind the diabetes pharma industry is a benefit we’ve started seeing more of in the past several years, thanks mostly to company engagement with the Diabetes Online Community.
Putting a face to the names of those behind the scenes making diabetes devices and products helps us all see that these organizations are made up of real, passionate people rather than just some “profit-hungry corporate types” we might imagine.
All of us in the Diabetes Community often wonder: What might the future of insulin look like, and how far out is the exciting new stuff we’re hearing about?
Well, we have a snapshot of some of the latest developments, but keep in mind that answers to the really key questions that resonate through all of this are elusive; no one really knows, but they sure like to guess.
A small biotech firm in Indiana…Read more »